This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Jane Wang - Innovator in Arginase Inhibitors
Introduction
Jane Wang is a notable inventor based in the United States. She has made significant contributions to the field of biochemistry, particularly in the development of arginase inhibitors. Her work focuses on addressing conditions characterized by abnormal arginase activity and nitric oxide levels in mammals.
Latest Patents
Jane Wang currently holds no patents. However, her patent application titled "Arginase Inhibitors And Methods Of Use Thereof" outlines innovative methods for treating or diagnosing conditions related to arginase activity. The invention includes a composition comprising an alpha-amino acid compound, or a derivative thereof, designed to improve health outcomes in affected mammals.
Career Highlights
Jane Wang is associated with AstraZeneca U.K. Limited, where she applies her expertise in biochemistry to advance medical research and development. Her work is crucial in the ongoing efforts to find effective treatments for various health conditions.
Collaborations
Some of her notable coworkers include Bruce Edward Tomczuk and Gary Lee Olson. Their collaborative efforts contribute to the innovative research environment at AstraZeneca.
Conclusion
Jane Wang is a dedicated inventor whose work on arginase inhibitors holds promise for future medical advancements. Her contributions to the field of biochemistry are noteworthy and reflect her commitment to improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile